GENE ONLINE|News &
Opinion
Blog

Treatment
GeneOnline’s Weekly News Highlights: Aug 21-25
2023-08-28
Introducing Veopoz™: A Breakthrough Treatment for CHAPLE Disease
2023-08-28
Potential Novel Anti-thrombotic Treatment by Ionis Pharmaceuticals
2022-07-28
Refining Psychedelics into Medicine – An Interview with Doug Drysdale, CEO of Cybin
2022-04-19
Japan Approves World’s First Therapy for Metastatic Non–Small Cell Lung Cancer with METex14
2020-03-26
Herceptin Hylecta bags FDA approval for HER2-Positive Breast Cancer Treatment
2019-03-04
First PARP inhibitor approved for 1L maintenance therapy of BRCAm advanced ovarian cancer
2018-12-28
Expedited Approval of Vitrakvi® Marks Many Firsts in Cancer Therapy
2018-12-04
Gilteritinib becomes first FLT3 targeted therapy for relapsed AML
2018-12-04
Pfizer’s Talzenna approved for breast cancer treatment
2018-10-25
Finding new pharmacological approach for neuroblastoma treatment
2018-10-16
LATEST
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
EVENT
Scroll to Top